Skip to main content
Caplight Logo









Anumana

Anumana

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://anumana.ai/

Last Round

Series C

Apr 24, 2025

Total Funding Raised

$181.1M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Anumana is a health technology company that develops AI-driven ECG algorithms to enhance early diagnosis and treatment through advanced predictive tools and biomarkers of disease.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Devices, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

software as a medical deviceSaMDECG AIcardiovascular AIdiagnostic decision supportclinical AIAI diagnosticsmedical imaging AIcardiac screeninghealth techFDA cleared AIdigital healthclinical workflow integrationAI in cardiologysmart diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Anumana Comparables

Compare Anumana with similar companies based on industry and business-model similarity.

Anumana comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pathway Labs
84%
GE HealthCare Technologies Inc.
82%
HEARTio
81%

Anumana Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CApr 24, 2025
Series BJun 1, 2022
Series AApr 14, 2021

Key People

Founding team and executive leadership

Harry Palmin

CFO

Executive Team

Anumana Investors

Notable investors and investment history

Anumana investors
InvestorRounds
MatrixSeries C, Series B, Series A
Matrix Capital ManagementSeries C, Series A
NTTVCSeries C, Series B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors grew 124% MoM, reaching 9.4K.

  • Apr 8, 2026

    FDA-cleared AI software for cardiac amyloidosis diagnosis launched.

Anumana Filings

Explore SEC and related filing metadata, where available.

Anumana filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Anumana's valuation, stock price, and market status.

Is Anumana a public or private company?

Anumana is a private company.

What is the current stock price of Anumana?

Anumana is a private company with no public stock price. No recent secondary market data is available.

How much is Anumana worth (valuation)?

Valuation information for Anumana is not publicly available.

Can I buy Anumana stock?

Anumana shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Anumana's last funding round?

Anumana's most recent funding round was Series C on April 24, 2025.

Who are the main investors in Anumana?

Key investors in Anumana include Matrix, Matrix Capital Management, NTTVC.

Will Anumana IPO soon?

No public IPO plans have been announced for Anumana.

How can I track Anumana secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Anumana's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range130
Year Founded2021
Last FundingApr 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?